GlassScriptPhysician profile
Todd S Cohen
NPI 1780665265
$17,141.26
in general payments reported to CMS, 2019-2025
54 companies · $2,390 in 2025
The $2,390 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,102 · 2020: $1,703 · 2021: $2,746 · 2022: $2,983 · 2023: $2,601 · 2024: $2,616 · 2025: $2,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,607.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,094.83 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $2,297.47 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $2,052.69 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Novartis Pharmaceuticals Corporation | $1,262.50 | 2019-2025 | |
| Boston Scientific Corporation | $1,164.49 | 2020-2025 | Bodyguardian, Accolade Sr, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $910.62 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $751.88 | 2019-2025 | Jardiance |
| Pfizer INC. | $728.65 | 2019-2025 | |
| Amgen INC. | $622.91 | 2020-2025 | Repatha, Repatha |
| Novo Nordisk INC | $488.77 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Irhythm Technologies, INC. | $444.75 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $438.67 | 2024-2025 | Amvuttra, Onpattro |
| Sanofi-Aventis U.S. LLC | $285.17 | 2019-2024 | |
| Scpharmaceuticals INC. | $264.60 | 2024-2025 | |
| Amarin Pharma, INC. | $216.40 | 2019-2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $214.22 | 2021-2025 | Verquvo, Capvaxive |
| Philips North America LLC | $201.68 | 2022-2024 | (5044) Mcot, (5050) Extended Holter |
| Esperion Therapeutics, INC. | $195.97 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.52 | 2019-2025 | Lifevest |
| Tactile Systems Technology INC | $130.93 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Neurelis, INC. | $125.00 | 2023 | Valtoco |
| Biotronik INC. | $103.55 | 2022-2025 | Biomonitor |
| Regeneron Healthcare Solutions, INC. | $83.03 | 2019-2025 | Evkeeza |
| Medtronic Vascular, INC. | $82.98 | 2020 | |
| Bridgebio Pharma, INC. | $76.72 | 2025 | Attruby |
| W. L. Gore & Associates, INC. | $63.99 | 2020-2022 | |
| Shockwave Medical, INC | $49.11 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $44.55 | 2023 | Impella |
| Daiichi Sankyo INC. | $43.05 | 2020-2022 | |
| Medtronic, INC. | $42.99 | 2025 | Onyx Frontier |
| Preventice Services, LLC | $37.00 | 2020-2021 | |
| Biosense Webster, INC. | $32.29 | 2019 | |
| Bardy Diagnostics, INC. | $31.00 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $27.74 | 2019-2021 | |
| Ge Healthcare | $24.88 | 2022 | |
| Cardiva Medical, INC. | $23.79 | 2024 | Cardiva Vascade 6/7f Vcs |
| Bard Peripheral Vascular, INC. | $23.20 | 2021 | |
| Glaxosmithkline, LLC. | $21.43 | 2025 | Shingrix, Arexvy |
| Lantheus Medical Imaging, INC. | $20.93 | 2022 | |
| Resmed Corp | $20.00 | 2022 | |
| Atricure, INC. | $19.18 | 2024 | |
| Heartflow, INC. | $18.33 | 2025 | |
| Medicomp INC | $18.14 | 2019 | |
| Edwards Lifesciences Corporation | $18.00 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $16.63 | 2025 | |
| Impulse Dynamics (USA) INC. | $16.30 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $15.64 | 2021-2025 | Rhythm Express |
| Amryt Pharma Holdings LTD | $14.34 | 2021 | |
| G Medical Diagnostic Services, INC. | $13.92 | 2022 | |
| Kestra Medical Technology Services, INC. | $13.91 | 2024 | Assure Wcd |
| Astellas Pharma US INC | $13.50 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $13.19 | 2023 | Inpefa |
| Akcea Therapeutics, INC. | $13.17 | 2019 | |
| Acarix USA INC. | $9.06 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.